Enzyme discovery could identify patients with diabetic neuropathy

07/16/2013 | MedPage Today (free registration)

An enzyme known as neuron-specific enolase becomes elevated in diabetes patients and even higher in those suffering from diabetic neuropathy, according to a study in Diabetes Care. The association is independent of the patient's glycemic state, age, sex or kidney function. "This may provide a potential blood marker for diabetic neuropathy," researchers said. Although diagnostic tools for diabetic neuropathy exist, there are as yet no specific biomarkers for neural damage.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC